Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ernexa Therapeutics Inc.NTN · Entity 8278 | Director · CEO | August 27, 2019 | August 27, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ernexa Therapeutics Inc.
Report date August 27, 2019 · Filed August 27, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,375 |
Reported balance
After 2019-08-27 transaction · row 1
1 source rowRow 1 · 2019-08-27 · Tax withholding · Disposed 241 · Balance 102,375 F1: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 27, 2019. No shares were sold in connection with this transaction. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 27, 2019. No shares were sold in connection with this transaction.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2019 Filed Aug 27, 2019 21:34 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 241 | $2.77 | $667.57 |
DisclosureSEC source: 0001493152-19-013434 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,375 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on August 27, 2019. No shares were sold in connection with this transaction. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 00:00 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 240 | $3.18 | $763.20 |
DisclosureSEC source: 0001493152-19-011372 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,616 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on July 30, 2019. No shares were sold in connection with this transaction. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 21:00 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 235 | $3.47 | $815.45 |
DisclosureSEC source: 0001493152-19-009630 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,856 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on June 21, 2019. No shares were sold in connection with this transaction. Read SEC document |
| May 21, 2019 Filed May 21, 2019 23:38 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 234 | $2.89 | $676.26 |
DisclosureSEC source: 0001493152-19-008044 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,091 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on May 21, 2019. No shares were sold in connection with this transaction. Read SEC document |
| April 23, 2019 Filed Apr 25, 2019 20:45 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 277 | $3.80 | $1,052.60 |
DisclosureSEC source: 0001493152-19-005943 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,325 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on April 23, 2019. No shares were sold in connection with this transaction. Read SEC document |
| March 26, 2019 Filed Mar 27, 2019 23:28 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 284 | $3.72 | $1,056.48 |
DisclosureSEC source: 0001493152-19-004043 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,603 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 26, 2019. No shares were sold in connection with this transaction. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:45 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-003712 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,887 F1 · shares: Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. The award will vest as to 16.67% of the shares subject to the award on the 6-month anniversary of the grant date and the remaining 83.33% of the shares will vest in 30 substantially equal monthly installments beginning on the 7-month anniversary of the grant date, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date. Read SEC document |
| February 26, 2019 Filed Feb 26, 2019 22:00 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 285 | $3.42 | $974.70 |
DisclosureSEC source: 0001493152-19-002607 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,887 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on February 26, 2019. No shares were sold in connection with this transaction. Read SEC document |
| January 29, 2019 Filed Jan 30, 2019 01:00 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 284 | $3.18 | $903.12 |
DisclosureSEC source: 0001493152-19-001143 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,172 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on January 29, 2019. No shares were sold in connection with this transaction. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 22:00 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 240 | $2.00 | $480.00 |
DisclosureSEC source: 0001493152-18-017754 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,456 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on December 19, 2018. No shares were sold in connection with this transaction. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 01:00 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 241 | $2.87 | $691.67 |
DisclosureSEC source: 0001493152-18-016583 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,696 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on November 20, 2018. No shares were sold in connection with this transaction. Read SEC document |
| October 23, 2018 Filed Oct 24, 2018 12:30 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 240 | $4.32 | $1,036.80 |
DisclosureSEC source: 0001493152-18-014820 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,937 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on October 23, 2018. No shares were sold in connection with this transaction. Read SEC document |
| September 25, 2018 Filed Sep 25, 2018 20:30 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | Tax withholdingCommon Stock | 1,441 | $4.23 | $6,095.43 |
DisclosureSEC source: 0001493152-18-013714 · ownership.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,177 F1 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on September 25, 2018. No shares were sold in connection with this transaction. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 20:58 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-003718 · form4.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,618 F1 · shares: Represents shares subject to a restricted stock unit award granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. The award will vest as to 16.67% of the shares subject to the award on the 6-month anniversary of the grant date and the remaining 83.33% of the shares will vest in 30 substantially equal monthly installments beginning on the 7-month anniversary of the grant date, in each case, subject to the reporting person's continued service to the issuer as of the applicable vesting date. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 01:59 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | GrantCommon Stock | 15,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-002430 · form4.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,618 F1 · shares: Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan and pursuant to the NTN Buzztime, Inc. Executive Incentive Plan for Eligible Employees of NTN Buzztime, Inc. Fiscal Year 2016, as amended (the 2016 EIP). Under the 2016 EIP, the decision to pay the incentive compensation earned in shares instead of in cash is made by the Nominating and Corporate Governance/Compensation Committee of the Board of Directors of the issuer at its discretion and in its sole determination. Read SEC document |
| November 04, 2016 Filed Nov 8, 2016 00:29 UTC | Ernexa Therapeutics Inc. NTN · Entity 8278 | GrantCommon Stock | 30,000 | $6.64 | $199,200.00 |
DisclosureSEC source: 0001493152-16-014598 · form4.xml · nonDerivative · entry 1 Krishnan Ram · CIK 0001618564 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,900 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.